BridgeMD
New treatment option for Copd
Official title Multidisciplinary Management of Severe COPD
ClinicalTrials.gov ID: NCT04860375
What this study is testing
- What it's testing
- Chronic Obstructive Pulmonary Disease (COPD) is a common chronic disease that is characterized by persistent airflow limitation, that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases, particularly cigarette smoking. Latest updates of the Global Burden of Disease emphasize the dramatic size of the problem.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 100
You may be able to join if
- Male or female patients, aged ≥40 years.
- Smokers or ex-smokers (≥10 pack-year).
- Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a...
- Signed informed concent form.
You likely can't join if
- Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative...
- Already enrolled in other studies perceived to interfere with this protocol.
- In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis).
- Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or...
- Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU.
- Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care.
See the full eligibility criteria
- Male or female patients, aged ≥40 years.
- Smokers or ex-smokers (≥10 pack-year).
- Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a clinically suspected diagnosis of exacerbations of COPD that prompt...
- Signed informed concent form.
- Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative diagnoses not related to patients with COPD (e.g., chest wall trauma...
- Already enrolled in other studies perceived to interfere with this protocol.
- In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis).
- Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or who make it impossible for the patients to participate into the study...
- Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU.
- Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care.
- At the discretion of the recruiting clinician would not be able to be considered for the study.
The study team makes the final eligibility decision.
Where it's taking place
- Gothenburg, VGR, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gothenburg, VGR, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.